News Update DCGI Approves Serum Institute’s ‘Covishield’ , Bharat Biotech ‘Covaxin’ Vaccines for Emergency Restricted Use 3 Jan 2021 India's drug controller Drugs Controller General of India(DCGI) has approved Serum Institute of India's 'Covishield' and Bharat Biotech's 'Covaxin' for restricted emergency use. This was informed by Dr VG Somani,…